Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Cell Transplantation Recipient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02860039
What this trial is testing

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Hematopoietic Cell Transplantation RecipientMalignant NeoplasmInfluenza
Vanderbilt-Ingram Cancer Center 170
Not applicableUnknownNCT06490549
What this trial is testing

An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)

Who this might be right for
RSV Infection
Institute of Hematology & Blood Diseases Hospital, China 500
Testing effectiveness (Phase 2)Study completedNCT01273207
What this trial is testing

Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

Who this might be right for
Bronchiolitis ObliteransConstructive BronchiolitisGraft Versus Host Disease+3 more
National Heart, Lung, and Blood Institute (NHLBI) 7
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Testing effectiveness (Phase 2)WithdrawnNCT03851081
What this trial is testing

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientBlasts 5 Percent or More of Bone Marrow Nucleated CellsBlasts 5 Percent or More of Peripheral Blood White Cells+5 more
Roswell Park Cancer Institute
Early research (Phase 1)Active Not RecruitingNCT04177004
What this trial is testing

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientHematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 52
Large-scale testing (Phase 3)Study completedNCT00980655
What this trial is testing

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Vaccines, Pneumococcal Conjugate Vaccine
Pfizer 251
Early research (Phase 1)Looking for participantsNCT03943238
What this trial is testing

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

Who this might be right for
Living Donor Kidney Transplantation
Stanford University 22
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Not applicableStudy completedNCT07716878
What this trial is testing

Isavuconazole Therapeutic Drug Monitoring in Transplant Recipients

Who this might be right for
Invasive Fungal InfectionsLung TransplantationHematopoietic Stem Cell Transplantation (HSCT)+2 more
Zhibin Xu 110
Not applicableStudy completedNCT01111201
What this trial is testing

International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

Who this might be right for
Breast CancerLymphoma
Memorial Sloan Kettering Cancer Center 26
Not applicableStudy completedNCT07692607
What this trial is testing

Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
LucasBio 25
Testing effectiveness (Phase 2)Ended earlyNCT04633187
What this trial is testing

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus Infections
Enanta Pharmaceuticals, Inc 9
Early research (Phase 1)Study completedNCT04220684
What this trial is testing

Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML

Who this might be right for
Allogeneic Stem Cell Transplant RecipientBlasts 10 Percent or More of Bone Marrow Nucleated CellsRecurrent Acute Myeloid Leukemia+1 more
Sumithira Vasu 19
Testing effectiveness (Phase 2)Ended earlyNCT01028716
What this trial is testing

Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Biphenotypic LeukemiaAcute Erythroid Leukemia in RemissionAcute Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 46
Testing effectiveness (Phase 2)Ended earlyNCT03195010
What this trial is testing

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+11 more
Fred Hutchinson Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT03565900
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 277
Not applicableNot Yet RecruitingNCT07324291
What this trial is testing

Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients

Who this might be right for
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONCarbapenem-resistant Enterobacterales
Institute of Hematology & Blood Diseases Hospital, China 1,000
Not applicableStudy completedNCT05208554
What this trial is testing

Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Caregivers

Who this might be right for
Hematopoietic Cell Transplant
Mayo Clinic 34
Not applicableStudy completedNCT04882605
What this trial is testing

KIR Sequencing and Typing for Allograft in Nancy

Who this might be right for
Stem Cell Transplant Complications
Central Hospital, Nancy, France 156
Next Page